Prostate-specific antigen

Results: 489



#Item
31The isolation of prostate cancer specific circulating tumor cells in the blood of patients with metastatic castration-resistant prostate cancer G. Theil 1, S. Schmidt 1, K. Fischer 1, K. Luecke, B 2. Nowack2, N. Mohammed

The isolation of prostate cancer specific circulating tumor cells in the blood of patients with metastatic castration-resistant prostate cancer G. Theil 1, S. Schmidt 1, K. Fischer 1, K. Luecke, B 2. Nowack2, N. Mohammed

Add to Reading List

Source URL: www.gilupi.de

Language: English - Date: 2014-05-27 05:36:39
32Collaborative Testing Services, Inc  FORENSIC TESTING PROGRAM Forensic Biology Test NoSummary Report This proficiency test was sent to 900 participants. Each participant received a sample pack consisting of two

Collaborative Testing Services, Inc FORENSIC TESTING PROGRAM Forensic Biology Test NoSummary Report This proficiency test was sent to 900 participants. Each participant received a sample pack consisting of two

Add to Reading List

Source URL: www.ctsforensics.com

Language: English - Date: 2015-05-14 19:40:14
33BioCentury,  THE BERNSTEIN R EPORT

BioCentury, THE BERNSTEIN R EPORT

Add to Reading List

Source URL: bindtherapeutics.com

Language: English - Date: 2014-03-18 13:29:02
34Bispecific PSMAxCD3 Diabody Novel Immunotherapeutic Agent for Prostate Cancer Technology In the field of cancer immunotherapy, the retargeting of T-cells to tumor cells by bispecific antibodies or diabodies is an appeali

Bispecific PSMAxCD3 Diabody Novel Immunotherapeutic Agent for Prostate Cancer Technology In the field of cancer immunotherapy, the retargeting of T-cells to tumor cells by bispecific antibodies or diabodies is an appeali

Add to Reading List

Source URL: www.campus-technologies.de

Language: English - Date: 2014-11-10 10:14:12
35The reinstatement (off cycle) program is an additional testing service offered to new or deficient laboratories that require a one time testing event. Ordering a reinstatement program does not constitute enrollment in ou

The reinstatement (off cycle) program is an additional testing service offered to new or deficient laboratories that require a one time testing event. Ordering a reinstatement program does not constitute enrollment in ou

Add to Reading List

Source URL: www.aab-pts.org

Language: English - Date: 2014-06-13 12:27:46
36MedicineToday  PEER REVIEWED ARTICLE Prostate cancer

MedicineToday PEER REVIEWED ARTICLE Prostate cancer

Add to Reading List

Source URL: www.prostate.com.au

Language: English - Date: 2007-01-01 20:57:21
37BVKC - SBCC Belgian Society for Clinical Chemistry Dear visitor  This is one of the presentations of the 2007 symposium of

BVKC - SBCC Belgian Society for Clinical Chemistry Dear visitor This is one of the presentations of the 2007 symposium of

Add to Reading List

Source URL: www.bvkc.be

Language: English - Date: 2007-10-01 21:30:16
381 Vol 16 Issue 4 – 5 Molecular Representations: REFLECTIONS ON MICROARRAYS AND PROSTATE CANCER Marko Monteiro

1 Vol 16 Issue 4 – 5 Molecular Representations: REFLECTIONS ON MICROARRAYS AND PROSTATE CANCER Marko Monteiro

Add to Reading List

Source URL: www.leoalmanac.org

Language: English - Date: 2014-02-11 08:13:49
39Quality of life in men undergoing treatment for prostate cancer Many of you may have participated in our prospective quality of life study looking at men undergoing treatment for localised prostate cancer. This article o

Quality of life in men undergoing treatment for prostate cancer Many of you may have participated in our prospective quality of life study looking at men undergoing treatment for localised prostate cancer. This article o

Add to Reading List

Source URL: www.prostate.com.au

Language: English - Date: 2009-04-02 01:05:29
40New Blood and Urine Tests to Improve Detection of Aggressive Prostate Cancer: Progress from the NCI Early Detection Research Network Martin G. Sanda, MD Professor and Chairman of Urology Emory University School of Medici

New Blood and Urine Tests to Improve Detection of Aggressive Prostate Cancer: Progress from the NCI Early Detection Research Network Martin G. Sanda, MD Professor and Chairman of Urology Emory University School of Medici

Add to Reading List

Source URL: edrn.nci.nih.gov

Language: English